相关实验视频

Updated: Jun 20, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

解密基因组分类器在前列腺癌中的临床影响

Sophia Li¹, Stephanie A Berg², Mutlay Sayan¹

¹Department of Radiation Oncology, Brigham and Women's Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

The Eurasian journal of medicine

|May 20, 2025

概括

解密基因组分类器 (GC) 改进了前列腺癌风险评估,超出了传统因素. 这种22基因测试有助于为局部前列腺癌患者个性化治疗决策.

科学领域:

基因组医学是一种基因组医学.
在瘤学瘤学.
前列腺癌研究前列腺癌研究.

背景情况:

传统的临床病理学因素不足以捕捉前列腺癌的异质性.
这可能导致局部性前列腺癌的过度治疗或治疗不足.
需要改进的工具来指导个性化治疗策略.

研究的目的:

评估解密基因组分类器 (GC) 在局部性前列腺癌中的临床实用性.
评估GC在完善风险分层和告知治疗决策方面的作用.
探索GC在不同风险群体和治疗后环境中的影响.

主要方法:

解密GC是一种22个基因表达的测试.
它的实用性在各种风险组 (低,中等,高) 中进行了评估.
评估了其在治疗前和治疗后决策中的作用.

主要成果:

解密GC在完善风险分层方面证明了临床实用性.
它有助于识别低风险疾病的积极监测候选人.
它有助于指导中等和高风险前列腺癌的治疗决策,包括前列腺切除术后的管理.

结论:

解读GC增强了局部性前列腺癌的风险分层和治疗个性化.
虽然追溯数据支持其预后价值,但前性验证正在进行中.
进一步的试验将澄清其对治疗反应的预测效用,并优化临床决策.

更多相关视频

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound

Published on: March 21, 2025

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...